Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8255 Sunitinib malate2 CitationTarget: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
- A2149 Bosutinib (SKI-606)1 CitationTarget: Bcr-Abl|SrcSummary: Potent Abl/Src kinases
- A2307 PHA-6657521 CitationTarget: c-METSummary: C-Met inhibitor,potent and ATP-competitive
- A1821 Ki8751Target: VEGFRSummary: VEGFR-2 inhibitor,potent and selective
- A2678 SU112742 CitationTarget: METSummary: C-Met inhibitor,potent and selective
- A2942 Masitinib (AB1010)Target: PDGFR|c-Kit|LynSummary: Tyrosine kinase inhibitor, potent and selective
- A2673 AG-1024Summary: Selective IGF-1R inhibitor
- A1389 WZ4002Summary: Mutant-selective EGFR inhibitor(L858R,T790M), irreversible and potent
- A5096 PF-04217903Target: c-METSummary: C-Met inhibitor,selective and ATP-competitive
- A1196 SGX-5231 CitationTarget: METSummary: MET inibitor, highly selective, ATP-competitive